ΨΥΧΟΛΟΓΙΑ - Έρευνα και Εφαρμογές ΤΕΥΧΟΣ 3 | Page 132

«ΨΥΧΟΛΟΓΙΑ έρευνα & εφαρμογές» Τόμος 1, Τεύχος 3, 2018 ISSN: 2623-3673
Bellentani S, Saccoccio G, Masutti F, et al. Prevalence of and risk factors for hepatic
steatosis in northern Italy. Ann Intern Med 2000; 132: 112–117
Bertola A, Mathews S, Ki SH, et al. Mouse model of chronic and binge ethanol
feeding (the NIAAA model). Nat Protoc 2013; 8(3): 627–637
Bird GL, Williams R. Factors determining cirrhosis in alcoholic liver disease. Mol
Aspects Med 1988; 10: 97–105
Bode JC, Biermann J, Kohse KP, Walker S, Bode C. High incidence of antibodies to
hepatitis C virus in alcoholic cirrhosis: fact or fiction? Alcohol Alcohol 1991; 26: 111–
114
Bruix J, Barrera JM, Calvet X, Ercilla G, Costa J, Sanchez-Tapias JM, Ventura M,
Vall M, Bruguera M, Bru C, Castillo R, Rodes J. Prevalence of antibodies to hepatitis
C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis.
Lancet 1989; ii: 1004–1006
Cohen SM, Ahn JSO. The diagnosis and management of alcoholic hepatitis. Aliment
Pharmacol Ther 2009; 30(1): 3–13
Collier JD, Woodall T, Wight DG, Shore S, Gimson AE, Alexander GJ. Predicting
progressive hepatic fibrosis stage on subsequent liver biopsy in chronic hepatitis C
virus infection. J Viral Hepat 2005; 12: 74–80
Corrao G, Bagnardi V, Zambon A, et al. Exploring the dose-response relationship
between alcohol consumption and the risk of several alcohol-related conditions: a
meta-analysis. Addiction 1999; 94: 1551–1573
Corrao G, Ferrari P, Zambon A, et al. Trends of liver cirrhosis mortality in Europe,
1970–1989: age period cohort analysis and changing alcohol consumption. Int J
Epidemiol 1997; 26(1): 100–109